MAIN ALAN J
SEC CIK 1227372 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | EVP, Innov, Chem Sciences | 339.1K | — | — | 8 | 2022-02-28 | 2025-02-28 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
MAIN ALAN J made no open-market trades at LXRX in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov, Chem Sciences | F - Tax | $0.67 | -43.4K | 339.1K | -11% | -$29.1K |
| DM | 2025-03-03 | 2025-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | +126.8K | 281.4K | +82% | — |
| DM | 2024-02-29 | 2024-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | +67.5K | 247.2K | +38% | — |
| D | 2024-02-29 | 2024-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov, Chem Sciences | F - Tax | $2.62 | -24.4K | 255.7K | -9% | -$63.9K |
| D | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov, Chem Sciences | F - Tax | $2.17 | -20.9K | 212.6K | -9% | -$45.5K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | +57.9K | 233.5K | +33% | — |
| DM | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | +54.6K | 163.1K | +50% | — |
| D | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov, Chem Sciences | F - Tax | $2.85 | -19.8K | 175.6K | -10% | -$56.3K |
Purchase Sale Sale after option exercise All abbreviations